Status:
UNKNOWN
The Role of Transdermal CO2 in MDA Level in Patient Underwent Abdominal Aortic Temporary Cross Clamp
Lead Sponsor:
Universitas Airlangga
Conditions:
Placenta Accreta
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
The Role of Transdermal Carbon Dioxide in Malondialdehyde Level as Predictor of Ischemia Reperfusion Injury in Patients Underwent Abdominal Aortic Temporary Cross Clamp
Detailed Description
Abdominal aortic temporary cross clamping procedures in patients with placenta accreta undergoing hysterectomy have been performed at Dr. Soetomo Hospital Surabaya for a period of 4 years. In the aort...
Eligibility Criteria
Inclusion
- Patients with Placenta Accreta diagnosed with placental accreta index (PAI) based on the results of ultrasound and underwent Abdominal Aorta Clamping Surgery (Control of Bleeding in Accreta)
Exclusion
- Patients with severe comorbid disorders based on previous clinical examination: chronic kidney disease, heart disease
- Patients with septic shock and sepsis
- Patients with peripheral artery disease
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05205304
Start Date
March 1 2022
End Date
December 31 2022
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hari Daswin Pagehgiri
Surabaya, Bali, Indonesia, 80116